Ralef - analogs
Components: Leflunomide |
|||||||||
Pharmgroups: Immunosuppressants || Selective immunosuppressants |
|||||||||
| Prices in pharmacies: 10.7-10.9€ Instructions Ralef | |||||||||
|
ⓘXEnter drugs for checking interactions through a quick button search . Interferon alpha-2b human recombinant+Diphenhydramine ✘ |
|
ⓘX diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘXAnalogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Leflunomide Canon | 2.7-10€ |
| ≈100% | neutral Leflunomide | 6.5-10€ |
| ≈100% | neutral Arava | 4.1-13.1€ |
| ≈100% | neutral Ehlafra | 9.4-11€ |
| ≈100% | neutral Leflaid | 18.9-19.6€ |
| ≈100% | neutral Lefomide | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘXAnalogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 79% — Скайризи neutral [Risankizumab]
- 68% — Кселтицин neutral [Tofacitinib]
- 68% — Тофацитиниб-АМЕДАРТ neutral [Tofacitinib]
- 68% — Ацинатиб neutral [Tofacitinib]
- 68% — Тофацитиниб-химрар neutral [Tofacitinib]
- 68% — Тофацитиниб Кроно neutral [Tofacitinib]
- 68% — Тофацитиниб Фармасинтез neutral [Tofacitinib]
- 68% — Тофацитиниб Дж neutral [Tofacitinib]
- 68% — Тофацитиниба цитрат neutral [Tofacitinib]
- 68% 350-446€ Jakvinus neutral [Tofacitinib]
- 67% 415€ Артлегиа neutral [Olokizumab]
- 67% 347.9€ Илсира neutral [Levilimab]
- 67% 649.6€ Kevzara neutral [Sarilumab]
- 65% — Барицитиниб neutral [Baricitinib]
- 65% — Баритрона neutral [Baricitinib]
- 65% — Барицитиниб Фармасинтез neutral [Baricitinib]
- 63% 415-436.2€ Otezla neutral [Apremilast]
- 61% — Tauredon neutral [Sodium aurothiomalate]
- 56% — Стилейкин neutral [Ustekinumab]
- 54% 380-415€ Ранвэк neutral [Upadacitinib]
- 54% 199.5€ Кинерет neutral [Anakinra]
- 53% 678.3-708.4€ Orensia neutral [Abatacept]
- 50% 221.7-235.4€ Efleira neutral [Netakimab]
- 50% 1699.3€ Stelara neutral [Ustekinumab]
- 50% — Апремиласт neutral [Apremilast]
- 50% — Апремиласт-29Ф neutral [Apremilast]
- 50% — Апремиласт ПСК neutral [Apremilast]
- 49% 321.8€ Тофара neutral [Tofacitinib and more 1Aspartame]
- 46% — Bioline Arthritis neutral [Bryonia alba and more 7Cimicifuga racemosa, Rhus toxicodendron, Coffea cruda, Colchicum autumnale, Dulcamara, Apis mellifica, Rhododendron chrysanthum]
- 43% 535€ Simponi neutral [Golimumab]
- 43% 91.9-416.9€ Enbrel neutral [Etanercept]
- 43% 194.8-385.8€ Этанерцепт ПСК neutral [Etanercept]
- 43% — Эрелзи neutral [Etanercept]
- 42% — Тавнеос neutral [Avacopan]
- 42% — Ривия neutral [Etanercept]
- 40% 0.6€ Sodium thiosulfate solution for injections neutral [Sodium thiosulfate]
- 40% 0.8€ Sodium thiosulfate neutral [Sodium thiosulfate]
- 40% — Byanodine neutral [Penicillamine]
- 40% 43.4-62.4€ Cuprenyl neutral [Penicillamine]
- 40% — Натрия тиосульфат велфарм neutral [Sodium thiosulfate]
- 40% — Пеницилламин-натив neutral [Penicillamine]
- 39% 240-490€ Simziya Negative 🔍 [Certolizumab paegol]
- 39% — Зепозия neutral [Ozanimod]
- 39% 700€ Entyvio neutral [Vedolizumab]
- 38% — Nalfon neutral [Fenoprofen]
- 38% — Relafen neutral [Nabumetone]
- 37% — Nescler Dangerous 🔍 [Fingolimod]
- 37% — Трибувиа neutral [Seniprutug]
- 36% 214.8€ Тофацитиниб neutral [Tofacitinib]
- 36% 1.4-6.7€ Comari tinctura neutral [Comari palustri rhizomatum tinctura]
Learn more about the selection of analogues
▶
- The drug has «Ralef» 7 full analogs, the cheapest - Leflunomide Canon (2.7-10€); 51 analog by action, the most similar - Jakvinus (350-446€).
- Medical online service has selected the best substitutes for Ralef based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ralef to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.